Recent Posts
- The Market Herald – Invex taps investors for $26.2m after positive Exenatide trials
- The West Australian – Biotech fires on Twiggy’s 11.8pc stake
- Biotech Daily – Dr Boreham’s Crucible – Why Invex has all the right ingredients to possibly become a takeover target
- Birmingham researcher awarded £1.68m to fund research in ‘raised brain pressure’
- Rare Disease Day
Recent Comments